⌘K

Home/Filings/4/0000899243-22-014737

4//SEC Filing

Waksal Harlan 4

Accession 0000899243-22-014737

CIK 0001327273other

View on SEC.gov Company Profile

Filed

Apr 12, 8:00 PM ET

Accepted

Apr 13, 7:16 PM ET

Size

4.8 KB

Accession

0000899243-22-014737

Insider Transaction Report

Form 4

Period: 2022-04-12

Lyra Therapeutics, Inc.LYRA

DirectorExecutive Chair

Transactions

Purchase
Common Stock
2022-04-12$4.22/sh+236,966$999,997→ 236,966 total

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Lyra Therapeutics, Inc.

CIK 0001327273

Entity typeother

Related Parties

1

filerCIK 0001449008

Filing Metadata

Form type: 4
Filed: Apr 12, 8:00 PM ET
Accepted: Apr 13, 7:16 PM ET
Size: 4.8 KB

View on SEC.gov